Patients' satisfaction with the community pharmacy services in Iran
Patients' satisfaction with the community pharmacy services in Iran

Ali Saffaei; Azadeh Moghaddas; Ali Mohammad Sabzghabaee

Volume 10, Issue 3 , July 2021, , Pages 133-137

Abstract
   This study aimed to measure patient satisfaction with community pharmacy in Isfahan, Iran, in 2019. Methods: In this cross-sectional study (2019), we selected 104 pharmacies ...  Read More
Reduced weekly subcutaneous doses of bortezomib in combination with cyclophosphamide and dexamethasone for newly diagnosed multiple myeloma
Reduced weekly subcutaneous doses of bortezomib in combination with cyclophosphamide and dexamethasone for newly diagnosed multiple myeloma

Farzaneh Ashrafi; Azadeh Moghaddas; Ali Darakhshandeh

Volume 9, Issue 1 , January 2020, , Pages 56-59

Abstract
   A combination of bortezomib, cyclophosphamide, and dexamethasone is highly effective in the treatment of newly diagnosed multiple myeloma. Neuropathy is a dose-limiting adverse ...  Read More
Management of febrile neutropenia: A description of clinical and microbiological findings by focusing on risk factors and pitfalls
Management of febrile neutropenia: A description of clinical and microbiological findings by focusing on risk factors and pitfalls

Fatemeh Karimi; Farzaneh Ashrafi; Azadeh Moghaddas; Ali Derakhshandeh

Volume 7, Issue 3 , July 2018, , Pages 147-156

Abstract
   Febrile neutropenia (FN) is one of the most serious clinical problems in patients with hematologic malignancies and patients receiving chemotherapy. The present study was implemented ...  Read More
Melatonin supplementation may improve the outcome of patients with hemorrhagic stroke in the intensive care unit
Melatonin supplementation may improve the outcome of patients with hemorrhagic stroke in the intensive care unit

Mehrnoush Dianatkhah; Atabak Najafi; Mohammad Sharifzadeh; Arezoo Ahmadi; Hamidreza Sharifnia; Mojtaba Mojtahedzadeh; Farhad Najmeddin; Azadeh Moghaddas

Volume 6, Issue 3 , July 2017, , Pages 173-177

Abstract
   Although mechanical ventilation is frequently a life-saving therapy, its use can result in unwanted side effects. It has been well documented that the choice of sedating agent ...  Read More
Osteonecrosis of the jaws in patient received bisphosphonates and sunitinib separately: A case report
Osteonecrosis of the jaws in patient received bisphosphonates and sunitinib separately: A case report

Farzaneh Ashrafi; Ali Derakhshandeh; Bijan Movahedian; Azadeh Moghaddas

Volume 6, Issue 3 , July 2017, , Pages 182-185

Abstract
  Recently published reports have suggested that antiangiogenic drugs such as sunitinib could potentiate the osteonecrosis of the jaw (ONJ) induced by bisphosphonates (BPs) and even induce ...  Read More
The content of plasma selenium in early admitted septic patients
The content of plasma selenium in early admitted septic patients

Omid Moradi Moghaddam; Mohammad Niakan Lahiji; Azadeh Moghaddas; Maryam Farasatinasab; Somayyeh Nasiripour

Volume 6, Issue 1 , January 2017, , Pages 52-55

Abstract
  Selenium depletion has been reported in critical illness correlates with an increase in mortality and morbidity. In this study, we aimed to access the selenium plasma levels of septic ...  Read More
A novel practical equation for treatment of emergent hypernatremia and dehydration phase in infants
A novel practical equation for treatment of emergent hypernatremia and dehydration phase in infants

Saba Ghaffary; Azadeh Moghaddas; Mehrnoush Dianatkhah

Volume 6, Issue 1 , January 2017, , Pages 56-59

Abstract
  Serum sodium (Na) concentration more than 145 mmol/L is defined as hypernatremia. Hypernatremia carries an acute morbidity and mortality, especially in neonates and infants. Rapid correction ...  Read More
Whether HER2-positive non-breast cancers are candidates for treatment with Ado-trastuzumab emtansine?
Whether HER2-positive non-breast cancers are candidates for treatment with Ado-trastuzumab emtansine?

Azadeh Moghaddas; Ali Borhani

Volume 5, Issue 4 , October 2016, , Pages 227-233

Abstract
  The National Comprehensive Cancer Network (NCCN) has recommended Ado-trastuzumab emtansine (T-DM1) as a preferred agent for patients with human epidermal growth factor receptor-2 (HER2)-positive ...  Read More